These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 34523023)

  • 21. One-year results of primary stenting for TASC II D lesions of the superficial femoral and popliteal arteries.
    Astarcıoglu MA; Kılıt C; Sen T; Durmus HI; Kalcık M; Gursoy MO; Yesın M; Asarcıklı LD; Gozubuyuk G; Amasyalı B
    Acta Cardiol; 2017 Feb; 72(1):36-40. PubMed ID: 28597743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease.
    Chan YC; Cheng SW; Cheung GC
    J Vasc Surg; 2015 Nov; 62(5):1201-9. PubMed ID: 26169015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K; Gable D; Hohman S; Pearl G; Theune B
    J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. One-Year Outcomes of Heparin-Bonded Stent-Graft Therapy for Real-World Femoropopliteal Lesions and the Association of Patency With the Prothrombotic State Based on the Prospective, Observational, Multicenter
    Iida O; Takahara M; Soga Y; Yamaoka T; Nanto S; Kuratani T; Sakata Y; Mano T
    J Endovasc Ther; 2021 Feb; 28(1):123-131. PubMed ID: 32959718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis.
    Sabeti S; Schillinger M; Amighi J; Sherif C; Mlekusch W; Ahmadi R; Minar E
    Radiology; 2004 Aug; 232(2):516-21. PubMed ID: 15286322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1-Year Results of the ZEPHYR Registry (Zilver PTX for the Femoral Artery and Proximal Popliteal Artery): Predictors of Restenosis.
    Iida O; Takahara M; Soga Y; Nakano M; Yamauchi Y; Zen K; Kawasaki D; Nanto S; Yokoi H; Uematsu M;
    JACC Cardiovasc Interv; 2015 Jul; 8(8):1105-1112. PubMed ID: 26117463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. French multicenter experience with the GORE TIGRIS Vascular Stent in superficial femoral and popliteal arteries.
    Sibé M; Kaladji A; Boirat C; Cardon A; Chaufour X; Bossavy JP; Saint-Lebes B
    J Vasc Surg; 2017 May; 65(5):1329-1335. PubMed ID: 28222987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BioMimics 3D vascular stent system for femoropopliteal interventions.
    Lichtenberg M; Zeller T; Gaines P; Piorkowski M;
    Vasa; 2022 Jan; 51(1):5-12. PubMed ID: 34878313
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term outcomes and risk stratification of patency following nitinol stenting in the femoropopliteal segment: retrospective multicenter analysis.
    Iida O; Soga Y; Hirano K; Suzuki K; Yokoi H; Nobuyoshi M; Muramatsu T; Inoue N; Nanto S; Uematsu M
    J Endovasc Ther; 2011 Dec; 18(6):753-61. PubMed ID: 22149222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative Outcomes of Supera Interwoven Nitinol vs Bare Nitinol Stents for the Treatment of Femoropopliteal Disease: Insights From the XLPAD Registry.
    Armstrong EJ; Jeon-Slaughter H; Kahlon RS; Niazi KA; Shammas NW; Banerjee S
    J Endovasc Ther; 2020 Feb; 27(1):60-65. PubMed ID: 31686573
    [No Abstract]   [Full Text] [Related]  

  • 31. Wire-Interwoven Nitinol Stent Outcome in the Superficial Femoral and Proximal Popliteal Arteries: Twelve-Month Results of the SUPERB Trial.
    Garcia L; Jaff MR; Metzger C; Sedillo G; Pershad A; Zidar F; Patlola R; Wilkins RG; Espinoza A; Iskander A; Khammar GS; Khatib Y; Beasley R; Makam S; Kovach R; Kamat S; Leon LR; Eaves WB; Popma JJ; Mauri L; Donohoe D; Base CC; Rosenfield K;
    Circ Cardiovasc Interv; 2015 May; 8(5):. PubMed ID: 25969545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of combined superficial femoral artery endovascular therapy with popliteal-to-distal bypass: A paradigm shift in surgical open bypass for chronic limb-threatening ischemia.
    Kobayashi T; Hamamoto M; Okazaki T; Hasegawa M; Fujiwara T; Takahashi S
    Vascular; 2021 Dec; 29(6):905-912. PubMed ID: 33349196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent.
    Soga Y; Iida O; Hirano K; Yokoi H; Nanto S; Nobuyoshi M
    J Vasc Surg; 2010 Sep; 52(3):608-15. PubMed ID: 20573476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitinol Stent Versus Bypass in Long Femoropopliteal Lesions: 2-Year Results of a Randomized Controlled Trial.
    Enzmann FK; Nierlich P; Aspalter M; Hitzl W; Dabernig W; Hölzenbein T; Ugurluoglu A; Seitelberger R; Linni K
    JACC Cardiovasc Interv; 2019 Dec; 12(24):2541-2549. PubMed ID: 31786218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions.
    Ohki T; Kichikawa K; Yokoi H; Uematsu M; Yamaoka T; Maeda K; Kanaoka Y
    J Vasc Surg; 2017 Jul; 66(1):130-142.e1. PubMed ID: 28400218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitinol stent implantation in TASC A and B superficial femoral artery lesions: the Femoral Artery Conformexx Trial (FACT).
    Zeller T; Tiefenbacher C; Steinkamp HJ; Langhoff R; Wittenberg G; Schlüter M; Buergelin K; Rastan A; Krumsdorf U; Sixt S; Schulte CL; Tübler T; Krankenberg H
    J Endovasc Ther; 2008 Aug; 15(4):390-8. PubMed ID: 18729564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and the clinical impact of stent fractures after primary stenting for TASC C and D femoropopliteal lesions at 1 year.
    Davaine JM; Quérat J; Guyomarch B; Brennan MÁ; Costargent A; Chaillou P; Patra P; Gouëffic Y
    Eur J Vasc Endovasc Surg; 2013 Aug; 46(2):201-12. PubMed ID: 23773773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-Expanding Nitinol Stent vs Percutaneous Transluminal Angioplasty in the Treatment of Femoropopliteal Lesions: 3-Year Data From the SM-01 Trial.
    Iida O; Urasawa K; Komura Y; Soga Y; Inoue N; Hara H; Yajima J; Nakamura S; Ohki T; Ando H; Hirano K; Horita Y; Kichikawa K; Yokoi Y; Miyamoto A; Nakamura M; Takahara M; Mano T; Nanto S
    J Endovasc Ther; 2019 Apr; 26(2):158-167. PubMed ID: 30702021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison Between Interwoven Nitinol and Drug Eluting Stents for Endovascular Treatment of Femoropopliteal Artery Disease.
    Haine A; Schmid MJ; Schindewolf M; Lenz A; Bernhard SM; Drexel H; Baumgartner I; Dopheide JF
    Eur J Vasc Endovasc Surg; 2019 Dec; 58(6):865-873. PubMed ID: 31668949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in self-expanding stents for use in the superficial femoral and popliteal arteries.
    Aghel A; Armstrong EJ
    Expert Rev Cardiovasc Ther; 2014 Jul; 12(7):833-42. PubMed ID: 24830846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.